Keunbon Ku

Title: Keunbon Ku: Innovator in Intracellular Delivery Systems

Introduction

Keunbon Ku is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for intracellular delivery systems. His work focuses on utilizing human-derived proteins to enhance the efficiency of delivering various materials into cells.

Latest Patents

Keunbon Ku holds a patent for a transmembrane domain derived from the human LRRC24 protein. This invention, known as the LRRC24P transmembrane domain, provides a novel approach to intracellular delivery. The transmembrane domain can effectively transport cargo materials, including compounds, biomolecules, and various polymer materials, into cells. Notably, the LRRC24P transmembrane domain exhibits higher cell penetration efficiency compared to conventional cell-penetrating peptides. This advantage is attributed to its human protein origin, which minimizes potential side effects and immune responses associated with foreign protein-derived peptides.

Career Highlights

Keunbon Ku is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance his research in biotechnology. His innovative work has positioned him as a key figure in the development of effective intracellular delivery methods.

Collaborations

He collaborates with notable colleagues, including Seong Jun Kim and Kyun Do Kim, who contribute to his research endeavors and help drive forward the advancements in the field.

Conclusion

Keunbon Ku's contributions to the field of biotechnology, particularly through his patented transmembrane domain, highlight the potential for human-derived proteins in enhancing intracellular delivery systems. His work not only advances scientific knowledge but also opens new avenues for therapeutic applications.